• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
Propofol

Propofol

Product ID P6870
Cas No. 2078-54-8
Purity ≥98%
Product Unit SizeCostQuantityStock
5 g $45.40 In stock
25 g $86.80 In stock
100 g $142.50 In stock
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

Propofol is an agonist at GABA-A receptors and antagonist at voltage-gated Na+ channels and NMDA receptors; it also modulates Ca2+ signaling. Propofol displays anesthetic, sedative/hypnotic, neuroprotective, and nephroprotective activities. Propofol is a short-acting intravenous anesthetic that depresses the central nervous system, decreases cerebral blood flow, and decreases intracranial pressure. In a middle cerebral artery occlusion (MCAO) model of cerebral ischemia/reperfusion, propofol decreases expression of aquaporins 1 and 4 (AQ-1 and AQ-4), matrix metalloproteinases 2 and 9 (MMP2/9), and HIF-1α, decreasing edema and disruption of the blood-brain barrier. Propofol also increases expression of μ-opioid receptors in neuroblastoma cells. Additionally, this compound normalizes osmolality, serum creatine, and levels of AQP-2, ICAM-1, TNF-α, Bcl-2, and Bax in kidneys, improving renal function in animal models of endotoxemia-induced kidney injury.

Product Info

Cas No.

2078-54-8

Purity

≥98%

Formula

C12H18O

Formula Wt.

178.27

IUPAC Name

2,6-di(propan-2-yl)phenol

Synonym

2,6-Bis(isopropyl)phenol, 2,6-Diisopropylphenol

Solubility

100mM in DMSO and ethanol

Appearance

Yellow to red liquid

Shipping and Storage

Store Temp

Ambient

Ship Temp

Ambient

Downloads

MSDS

P6870 MSDS PDF

Info Sheet

P6870 Info Sheet PDF

References

Lee JH, Cui HS, Shin SK, et al. Effect of propofol post-treatment on blood-brain barrier integrity and cerebral edema after transient cerebral ischemia in rats. Neurochem Res. 2013 Nov;38(11):2276-86. PMID: 23990224.

Li Z, Pei Q, Cao L, et al. Propofol increases µ-opioid receptor expression in SH-SY5Y human neuroblastoma cells. Mol Med Rep. 2012 Dec;6(6):1333-6. PMID: 22965315.

Cui WY, Tian AY, Bai T. Protective effects of propofol on endotoxemia-induced acute kidney injury in rats. Clin Exp Pharmacol Physiol. 2011 Nov;38(11):747-54. PMID: 21824173.

Kotani Y, Shimazawa M, Yoshimura S, et al. The experimental and clinical pharmacology of propofol, an anesthetic agent with neuroprotective properties. CNS Neurosci Ther. 2008 Summer;14(2):95-106. PMID: 18482023.

Salmi E, Kaisti KK, Metsähonkala L, et al. Sevoflurane and propofol increase 11C-flumazenil binding to gamma-aminobutyric acidA receptors in humans. Anesth Analg. 2004 Nov;99(5):1420-6. PMID: 15502041.

Yamanoue T, Brum JM, Estafanous FG. Vasodilation and mechanism of action of propofol in porcine coronary artery. Anesthesiology. 1994 Aug;81(2):443-51. PMID: 8053594.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • G4797

    GLYX-13 Trifluoroacetate

    Peptide; NMDA partial agonist.

    ≥98%
  • D1759

    Deoxynivalenol

    Trichothecene mycotoxin produced by Fusarium.

    ≥98%, TLC
  • I7074

    Irsogladine Maleate

    NSAID; COX-1/2 and PDE inhibitor.

    ≥98%
  • P327211

    Pifithrin-α Hydrobromide

    p53 inhibitor

    ≥98%
  • F1895

    Fexofenadine Hydrochloride

    Histamine H1 antagonist.

    ≥98%
  • R2711

    Recombinant HCV-Core Antigens

    Recombinant HIV core protein antigen fragment.<...

    ≥95%
  • H5750

    Homoharringtonine

    Alkaloid found in Cephalotaxus; ribosomal prote...

    ≥97%
  • L9600

    LY-2090314

    GSK-3 inhibitor.

    ≥98%
  • A4803

    Amantadine Sulfate

    Viral M2 proton channel blocker, MAO-A, NET, NM...

    ≥98%
  • B5728

    Bohemine

    Purine derivative; CDK inhibitor.

    ≥98%
  • C5870

    Corosolic Acid

    Pentacyclic triterpene found in the Banaba plan...

    ≥98%
  • B3211

    (+)-Bicuculline

    NMDA potentiator, GABA-A antagonist.

    ≥98%
  • F6803

    FRAX486

    PAK inhibitor.Smo inhibitor.

    ≥98%
  • S0459

    SB-590885

    B-Raf inhibitor.

    ≥97%
  • K0552

    Kb NB 77-78

    CID-797718 analog; potential PKD1 binding agent...

    ≥98%
  • C3210

    Ciglitazone

    Thiazolidinedione; PPARγ agonist.

    ≥98%
  • T2933

    4-Thiouridine

    Modified nucleotide used for labeling DNA; DNA ...

    ≥99%
  • P7034

    Prion Peptide (106-126), human

    Synthetic peptide fragment, prion protein analo...

    ≥95%
  • M5877

    Motesanib Diphosphate

    VEGFR, PDGFR, c-Kit, RET inhibitor.

    ≥98%
  • A480020

    (R,S)-AM 1241

    Cannabinoid receptor 2 selective agonist.

    ≥96%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2025 LKT Laboratories, All Rights Reserved - Products for research use only